Skip to main content
Caplight Logo









Groff North America

Groff North America

Private
Red Lion, PennsylvaniaHealthcare & Life Scienceshttps://groffna.com/

Last Round

Series B

Oct 31, 2023

Total Funding Raised

$7.5M

Company Overview

Groff North America is a biotechnology company that specializes in the research, development, and manufacturing of pharmaceutical-grade cannabis and hemp-based therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Compliance

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

botanical APIactive pharmaceutical ingredientAPIDEA schedule Icannabinoid researchbotanical drug discoverybiotech pharmamolecular breedingclinical trial materialsai drug discoverycontract research organizationCROgenomic probe technologycustom formulationspharma supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Groff North America Comparables

Compare Groff North America with similar companies based on industry and business-model similarity.

Groff North America comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Royal Emerald Pharmaceuticals
88%
Irvine Labs, Inc.
86%
BRC Bio
85%

Groff North America Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 31, 2023
Growth EquityJul 17, 2023
Early FundingNov 14, 2019

Groff North America Investors

Notable investors and investment history

Groff North America investors
InvestorRounds
Kinsley EnterprisesEarly Funding, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors increased 83% MoM.

  • Oct 31, 2023

    Led by Kinsley Enterprises

Groff North America Filings

Explore SEC and related filing metadata, where available.

Groff North America filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Groff North America's valuation, stock price, and market status.

Is Groff North America a public or private company?

Groff North America is a private company.

What is the current stock price of Groff North America?

Groff North America is a private company with no public stock price. No recent secondary market data is available.

How much is Groff North America worth (valuation)?

Valuation information for Groff North America is not publicly available.

Can I buy Groff North America stock?

Groff North America shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Groff North America's last funding round?

Groff North America's most recent funding round was Early Funding on October 31, 2023.

Who are the main investors in Groff North America?

Key investors in Groff North America include Kinsley Enterprises.

Will Groff North America IPO soon?

No public IPO plans have been announced for Groff North America.

How can I track Groff North America secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Groff North America's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRed Lion, Pennsylvania
Employee Range8
Year Founded2018
Last FundingOct 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?